Dynatrace
DT
$39.21
-2.54%
Dynatrace, Inc. is a software-as-a-service company that provides a unified platform for monitoring and analyzing IT infrastructure, applications, and machine-generated data in real-time, operating within the Software - Application industry. The company is a recognized leader in the application performance monitoring and observability space, distinguished by its AI-powered, automated intelligence platform. The current investor narrative is dominated by the broader 'SaaS Apocalypse' fears and sector-wide AI disruption, with recent news highlighting the company's aggressive share buyback program as a signal of management confidence amidst this volatile market backdrop for software stocks.…
DT
Dynatrace
$39.21
Investment Opinion: Should I buy DT Today?
Rating & Thesis: Hold. Dynatrace presents a compelling but high-risk value proposition for patient investors, as its premium fundamentals are currently overshadowed by severe technical damage and sector-wide derating. The unanimous bullish institutional sentiment and aggressive buybacks signal insider confidence, but these have not yet arrested the downtrend.
Supporting Evidence: The stock trades at a forward PE of 19.65x, a significant discount to its trailing PE of 29.09x, implying the market expects ~48% EPS growth. This multiple is roughly in line with the software sector average, yet Dynatrace offers superior gross margins of 81.4% and robust FCF generation ($465.7M TTM). Revenue continues to grow at a healthy 18.18% YoY, and the balance sheet is fortress-like with minimal debt (D/E 0.029). However, the 25.63% six-month price decline and 49.76% annual underperformance versus the S&P 500 demonstrate powerful selling pressure that fundamentals have yet to overcome.
Risks & Conditions: The two biggest risks are 1) further growth deceleration below 15% YoY, and 2) a breakdown below the $31.64 technical support triggering a new leg down. This Hold rating would upgrade to a Buy if the stock stabilizes above $40 on sustained volume, revenue growth re-accelerates above 20% YoY, or the forward PE compresses below 17x while growth remains intact. It would downgrade to a Sell if QoQ net income declines further, revenue growth drops below 15%, or the $31.64 support is decisively broken. Relative to its own history and sector peers, the stock appears fairly valued to slightly undervalued, but the valuation discount is justified by the elevated execution and macro risks.
Sign up to view all
DT 12-Month Price Forecast
Dynatrace is a high-quality business caught in a severe sector-wide storm. Its robust fundamentals and compressed valuation suggest long-term value, but the powerful downtrend and growth deceleration warrant caution. The base case (50% probability) of range-bound trading is most likely, as the company's execution is unlikely to deteriorate sharply, but sector headwinds will prevent a swift re-rating. The stance would upgrade to bullish on evidence of growth stabilization above 20% or a successful technical reclaim of the $45 level. It would turn bearish on a breakdown below $31.64 or a drop in revenue growth below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dynatrace's 12-month outlook, with a consensus price target around $50.97 and implied upside of +30.0% versus the current price.
Average Target
$50.97
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$31 - $51
Analyst target range
Insufficient analyst coverage data is available to calculate a precise consensus, as the provided data indicates only one analyst providing estimates. This limited coverage, despite the company's $14 billion market cap, is unusual and may indicate it is transitioning from a mid-cap to a large-cap stock, or that analyst coverage has consolidated. The available institutional ratings from February 2026 show a unanimously bullish sentiment, with firms including BTIG, Barclays, Wells Fargo, and Keybanc all maintaining Buy, Overweight, or Outperform ratings; no downgrades or Sell ratings were reported in the recent data. The lack of a broad consensus target price and the minimal analyst count suggest that while following institutions are positive, broader Wall Street coverage may be limited, which can contribute to higher volatility and less efficient price discovery as the stock reacts more to fundamental results than to analyst revisions.
Bulls vs Bears: DT Investment Factors
The investment debate for Dynatrace centers on a clash between deteriorating technical momentum and decelerating growth against a backdrop of exceptional fundamental strength and deeply compressed valuation. Currently, the bear case holds stronger short-term evidence, given the stock's severe underperformance, clear growth deceleration from 22% to 18%, and persistent sector headwinds. However, the bull case is built on a durable foundation of pristine financials, high margins, and a valuation at historical lows that may already price in significant pessimism. The single most important tension is whether the company's robust 18% growth and 81% gross margins can stabilize and eventually justify a valuation re-rating, or if the 'SaaS Apocalypse' narrative and competitive AI disruption will lead to further growth deceleration and multiple compression.
Bullish
- Exceptional Financial Health: The balance sheet is pristine with a debt-to-equity ratio of only 0.029, and the company generates robust free cash flow, with TTM FCF of $465.7 million. This financial fortress, evidenced by a current ratio of 1.40, funds aggressive shareholder returns, including $160 million in buybacks last quarter, signaling strong management confidence.
- Premium Profitability & Recurring Revenue: Dynatrace boasts an industry-leading gross margin of 81.41%, supporting a net margin of 7.77%. Revenue is 95.7% subscription-based, providing high visibility and stability, with the latest quarter showing 18.18% YoY growth to $515.5 million despite sector headwinds.
- Valuation at Historical Lows: The stock's trailing PE of 29.09x and forward PE of 19.65x represent a dramatic compression from historical peaks above 90x. This derating to near multi-year lows, while revenue grows at 18%, suggests the market's punitive 'SaaS Apocalypse' sentiment may have overshot, creating a potential value opportunity.
- Strong Institutional Conviction: Despite limited broad analyst coverage, the available institutional ratings from February 2026 are unanimously bullish (BTIG, Barclays, Wells Fargo, Keybanc). This concentrated support, coupled with the aggressive buyback program, indicates deep-pocketed investors see fundamental value at current prices.
Bearish
- Severe Technical & Relative Weakness: The stock is in a pronounced downtrend, down 20.72% over the past year and 25.63% over six months, severely underperforming the S&P 500 by 49.76% over one year. Trading at 65% of its 52-week range near $37.61, it remains vulnerable to a breakdown below key support at $31.64.
- Growth Deceleration & Margin Volatility: Q3 revenue growth of 18.18% YoY marks a sequential deceleration from the ~22% pace implied in prior quarters. Concurrently, net income fell from $57.2M in Q2 to $40.1M in Q3, indicating inconsistent profitability and potential margin pressure from investments amid slowing top-line expansion.
- Sector-Wide Multiple Compression Risk: The stock's beta of 0.79, atypically low for a growth SaaS name, suggests it has been less volatile than the market on the way down, potentially due to heavy institutional ownership. This leaves it exposed to further sector-wide derating if the 'SaaS Apocalypse' narrative persists, compressing its forward PE of 19.65x further.
- Limited Analyst Coverage & Visibility: Only one analyst provides estimates, creating a lack of consensus targets and potentially less efficient price discovery for this $14B market cap company. This limited coverage heightens volatility risk, as the stock may react more sharply to fundamental results without analyst guidance to anchor expectations.
DT Technical Analysis
The stock is in a pronounced downtrend, having declined 20.72% over the past year and 25.63% over the last six months, significantly underperforming the broader market. With a current price of $37.61, it is trading at approximately 65% of its 52-week range, positioned closer to its 52-week low of $31.64 than its high of $57.55, suggesting the stock is in a value-seeking zone but remains vulnerable to further downside if the fundamental outlook deteriorates. Recent momentum shows a slight divergence, with a 2.28% gain over the past month contrasting with a 1.26% loss over three months; however, this short-term uptick is weak and has occurred alongside severe negative relative strength, underperforming the S&P 500 by 7.70% over one month and 49.76% over one year, indicating persistent selling pressure and a lack of conviction in the rebound. Key technical support is firmly established at the 52-week low of $31.64, while resistance lies near the 52-week high of $57.55; a sustained breakdown below $31.64 would signal a new leg down, whereas reclaiming the $40-$45 zone is necessary for any recovery thesis. The stock's beta of 0.79 indicates it has been less volatile than the market during this decline, which is atypical for a growth software name and may reflect heavy institutional ownership or a lack of speculative interest.
Beta
0.70
0.70x market volatility
Max Drawdown
-42.9%
Largest decline past year
52-Week Range
$32-$58
Price range past year
Annual Return
-22.3%
Cumulative gain past year
| Period | DT Return | S&P 500 |
|---|---|---|
| 1m | +21.2% | +8.6% |
| 3m | +5.6% | +6.7% |
| 6m | -16.2% | +9.8% |
| 1y | -22.3% | +26.6% |
| ytd | -7.4% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DT Fundamental Analysis
Revenue growth remains healthy but shows signs of sequential deceleration; the most recent quarterly revenue was $515.47 million, representing a solid 18.18% year-over-year increase, yet this marks a slowdown from the 21.8% YoY growth implied in the prior quarter's $493.85 million revenue. The business is overwhelmingly driven by subscriptions, which constituted $493.37 million (95.7%) of last quarter's revenue, indicating a stable, recurring model. The company is profitable with a net income of $40.06 million last quarter, supported by an exceptionally strong gross margin of 81.41%; however, operating margins are more modest at 14.11% (operating income ratio), and the net margin of 7.77% reflects significant tax and other expenses. Profitability has been inconsistent on a quarterly basis, with net income declining from $57.24 million in Q2 to $40.06 million in Q3, suggesting potential margin pressure from investments or one-time items. The balance sheet is exceptionally strong with minimal debt, evidenced by a debt-to-equity ratio of just 0.029, and robust liquidity with a current ratio of 1.40. The company generates substantial free cash flow, with TTM FCF of $465.73 million, providing ample internal funding for growth and its aggressive share repurchase program, as seen in the $160 million of buybacks in the last quarter alone; this financial flexibility is a key pillar of the investment case amidst sector uncertainty.
Quarterly Revenue
$515473000.0B
2025-12
Revenue YoY Growth
+0.18%
YoY Comparison
Gross Margin
+0.81%
Latest Quarter
Free Cash Flow
$465728999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DT Overvalued?
Given the company's consistent profitability (Net Income > 0), the primary valuation metric is the Price-to-Earnings (PE) ratio. Dynatrace trades at a trailing PE of 29.09x and a forward PE of 19.65x based on estimated EPS. The significant discount of the forward multiple implies the market expects robust earnings growth, with the forward PE pricing in an approximate 48% growth in EPS from the trailing figure. Compared to sector averages (data not explicitly provided in the input, but typical Software industry averages are in the low 20s for forward PE), a forward PE of 19.65x suggests Dynatrace is trading roughly in line with or at a slight discount to its peers, which may not fully account for its superior gross margins and strong FCF generation. Historically, the stock's own valuation has compressed dramatically; its current trailing PE of 29.09x is near the bottom of its multi-year range, down from peaks above 90x seen in 2023 and 2024. This compression to near-historical lows reflects the market's derating of SaaS multiples and suggests that if the company can sustain its growth and profitability, the current price may represent a value opportunity relative to its own history, though it also signals lowered growth expectations.
PE
29.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~3616x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
57.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Dynatrace's primary financial risk is not leverage but earnings volatility and growth sustainability. Net income declined 30% sequentially from Q2 to Q3 ($57.2M to $40.1M), indicating margin pressure despite an 81.4% gross margin. Revenue growth decelerated to 18.18% YoY, and with 95.7% of revenue from subscriptions, the model is heavily dependent on net revenue retention and new customer acquisition to maintain this pace. While free cash flow generation is strong at $465.7M TTM, a prolonged growth slowdown could challenge the current valuation which embeds a forward PE of 19.65x, implying high earnings growth expectations.
Market & Competitive Risks: The stock faces acute valuation compression risk, having already seen its trailing PE collapse from peaks above 90x to 29.09x. A forward PE of 19.65x, while in line with sector averages, may not be safe if the broader market continues to derate SaaS multiples amid the 'SaaS Apocalypse' and AI disruption fears highlighted in recent news. Its low beta of 0.79 suggests it has been less volatile than the market during the decline, but this atypical characteristic for a growth stock may reflect a lack of speculative interest, leaving it vulnerable to further outflows if institutional conviction wavers. Competitive risks from larger platform vendors and newer AI-native observability tools could pressure its premium pricing and market leadership.
Worst-Case Scenario: The most damaging scenario involves a combination of a severe macroeconomic downturn impacting IT budgets, competitive share loss leading to a growth stall below 10%, and a sector-wide re-rating pushing its forward PE toward 15x. This could trigger a breakdown below the key $31.64 support (52-week low), leading to a capitulation sell-off. Given the stock's 52-week high of $57.55 and current price of $37.61, a realistic downside in this adverse scenario could see a decline of approximately 35-40%, retesting the $31.64 low and potentially breaching it to the $28-$30 range, representing a loss of roughly $6-$9 per share from current levels.
FAQ
The key risks are: 1) Growth Deceleration: Revenue growth slowed to 18.18% YoY last quarter; a further drop could crush the valuation multiple. 2) Sector & Valuation Risk: The stock is exposed to the broader 'SaaS Apocalypse' derating; its forward PE of 19.65x could compress further if sector sentiment worsens. 3) Competitive Disruption: As a leader in APM/Observability, it faces intense competition from larger cloud platforms and newer AI-native tools, which could pressure its premium pricing and margins. 4) Technical Breakdown: With the stock down 25.6% in six months and trading near its 52-week low of $31.64, a break below this key support could trigger accelerated selling, potentially leading to a 35%+ drawdown from current prices.
Our 12-month forecast outlines three scenarios with associated probabilities. The Base Case (50% probability) sees the stock trading between $38 and $45 as growth stabilizes around 18% and the forward PE remains near 19-22x. The Bull Case (30% probability) targets $48 to $57, requiring growth re-acceleration above 20% and a sector multiple expansion. The Bear Case (20% probability) warns of a drop to $28-$32 if growth decelerates further and technical support at $31.64 fails. The most likely outcome is the Base Case, which assumes the company executes steadily but continues to be weighed down by sector overhangs, resulting in range-bound, volatile trading.
DT appears fairly valued to slightly undervalued relative to its current fundamentals but richly valued relative to its declining growth rate. Its forward PE of 19.65x is roughly in line with the software sector average, yet it boasts superior gross margins (81.4% vs. typical 70-75%) and a pristine balance sheet. However, compared to its own history where it traded above 90x earnings, the current ~29x trailing PE represents a dramatic de-rating. The valuation implies the market expects robust earnings growth (forward PE discounts trailing by 48%) but also prices in significant execution and sector risk. It is not deeply undervalued, but it is no longer egregiously overvalued as it was at its peaks.
DT is a high-conviction, high-risk opportunity at current levels. For investors with a 2-3 year horizon and tolerance for volatility, the combination of a forward PE of 19.65x, 18% revenue growth, and an 81% gross margin presents a compelling risk/reward if the company can stabilize its growth trajectory. The unanimous bullish institutional ratings and aggressive buyback program signal insider confidence. However, it is not a good buy for short-term traders or risk-averse investors, given its 25% six-month decline and persistent underperformance. A good entry would be on further weakness toward the $32-$34 support zone, with a clear plan to average down if the fundamental thesis remains intact.
DT is unsuitable for short-term trading due to its high volatility, negative momentum, and lack of near-term positive catalysts. It is best suited for a long-term investment horizon of 3+ years. This allows time for the company to demonstrate it can navigate competitive and sector challenges, for its growth rate to potentially re-stabilize, and for the compressed valuation to mean-revert if execution proves sound. The stock's low beta of 0.79 is misleading given its severe drawdown; it remains a volatile growth stock. The absence of a dividend further emphasizes a total return strategy dependent on capital appreciation over time.